Enanta Pharmaceuticals (ENTA) Change in Receivables (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Change in Receivables of -$684000.0 for Q1 2026, up 26.13% year-on-year from -$542280.8 in Q1 2025, and down 142.46% on a QoQ basis from $1.6 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Change in Receivables data on file, last reported at -$684000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 26.13% year-over-year to -$684000.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 205.5% YoY), and the FY2025 full-year result was $236000.0, up 111.99% from the prior year.
- Change in Receivables for Q1 2026 stood at -$684000.0, down from $1.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.3 million in Q4 2022 and bottomed at -$10.3 million in Q3 2023.
- The 5-year median for Change in Receivables is -$417000.0 (2024), against an average of -$1.2 million.
- The widest annual swing landed in 2023, when Change in Receivables plunged 1325.03%; it then surged 343.08% in 2024.
- A 5-year view of Change in Receivables shows it stood at $2.3 million in 2022, then slumped by 119.45% to -$441000.0 in 2023, then surged by 343.08% to $1.1 million in 2024, then surged by 50.28% to $1.6 million in 2025, then sank by 142.46% to -$684000.0 in 2026.
- The last three Change in Receivables figures came in at -$684000.0 (Q1 2026), $1.6 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -684,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -684,000.00 |
| Mar 31, 2026 | -684,000.00 |
| Dec 31, 2025 | 1.61 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | -926,000.00 |
| Mar 31, 2025 | -926,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -1.53 Mn |
| Sep 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | 420,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | -417,000.00 |
| Mar 31, 2024 | -417,000.00 |
| Dec 31, 2023 | -441,000.00 |
| Dec 31, 2023 | -441,000.00 |
| Sep 30, 2023 | -10.28 Mn |
| Sep 30, 2023 | -10.28 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | -4.79 Mn |
| Mar 31, 2023 | -4.79 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 839,000.00 |
| Sep 30, 2022 | 839,000.00 |
| Jun 30, 2022 | 763,000.00 |
| Jun 30, 2022 | 763,000.00 |
| Mar 31, 2022 | -8.93 Mn |
| Mar 31, 2022 | -8.93 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 1.49 Mn |
| Mar 31, 2021 | -11.61 Mn |
| Mar 31, 2021 | -11.61 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Dec 31, 2020 | 8.25 Mn |
| Sep 30, 2020 | 4.84 Mn |
| Sep 30, 2020 | 4.84 Mn |
| Jun 30, 2020 | -8.97 Mn |
| Jun 30, 2020 | -8.97 Mn |
| Mar 31, 2020 | -24.95 Mn |
| Mar 31, 2020 | -24.95 Mn |
| Dec 31, 2019 | 1.26 Mn |
| Dec 31, 2019 | 1.26 Mn |
| Sep 30, 2019 | 6.95 Mn |
| Sep 30, 2019 | 6.95 Mn |
| Jun 30, 2019 | 4.74 Mn |
| Jun 30, 2019 | 4.74 Mn |
| Mar 31, 2019 | -30.26 Mn |
| Mar 31, 2019 | -30.26 Mn |
| Dec 31, 2018 | 2.68 Mn |
| Dec 31, 2018 | 2.68 Mn |
| Sep 30, 2018 | 9.94 Mn |
| Sep 30, 2018 | 9.94 Mn |
| Jun 30, 2018 | 13.21 Mn |
| Jun 30, 2018 | 13.21 Mn |
| Mar 31, 2018 | 20.94 Mn |
| Mar 31, 2018 | 20.94 Mn |
| Dec 31, 2017 | 12.50 Mn |
| Dec 31, 2017 | 12.50 Mn |
| Sep 30, 2017 | 3.10 Mn |
| Sep 30, 2017 | 3.10 Mn |
| Jun 30, 2017 | -1.45 Mn |
| Jun 30, 2017 | -1.45 Mn |
| Mar 31, 2017 | -1.46 Mn |
| Mar 31, 2017 | -1.46 Mn |
| Dec 31, 2016 | -2.42 Mn |
| Dec 31, 2016 | -2.42 Mn |
| Sep 30, 2016 | -1.14 Mn |
| Sep 30, 2016 | -1.14 Mn |
| Jun 30, 2016 | 974,000.00 |
| Jun 30, 2016 | 974,000.00 |
| Mar 31, 2016 | -4.87 Mn |
| Mar 31, 2016 | -4.87 Mn |
| Dec 31, 2015 | 2.58 Mn |
| Dec 31, 2015 | 2.58 Mn |
| Sep 30, 2015 | 3.57 Mn |
| Sep 30, 2015 | 3.57 Mn |
| Jun 30, 2015 | 4.64 Mn |
| Jun 30, 2015 | 4.64 Mn |
| Mar 31, 2015 | -69.55 Mn |
| Mar 31, 2015 | -69.55 Mn |
| Dec 31, 2014 | 74.90 Mn |
| Dec 31, 2014 | 74.90 Mn |
| Sep 30, 2014 | 1.33 Mn |
| Sep 30, 2014 | 1.33 Mn |
| Jun 30, 2014 | -599,000.00 |
| Jun 30, 2014 | -599,000.00 |
| Mar 31, 2014 | 719,000.00 |
| Mar 31, 2014 | 719,000.00 |
| Dec 31, 2013 | -529,000.00 |
| Dec 31, 2013 | -529,000.00 |
| Sep 30, 2013 | -68,000.00 |
| Sep 30, 2013 | -68,000.00 |
| Jun 30, 2013 | 207,000.00 |
| Jun 30, 2013 | 207,000.00 |
| Mar 31, 2013 | -13.66 Mn |
| Mar 31, 2013 | -13.66 Mn |
| Dec 31, 2012 | 13.28 Mn |
| Dec 31, 2012 | 13.28 Mn |
| Sep 30, 2012 | -924,000.00 |
| Sep 30, 2012 | -924,000.00 |
| Jun 30, 2012 | 1.89 Mn |
| Jun 30, 2012 | 1.89 Mn |